Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by

Newcastle AuthorsTitleYearFull text
Julie Errington
Pharmacokinetics and safety of a novel oral liquid formulation of 13-cis retinoic acid in children with neuroblastoma: A randomized crossover clinical trial2021
Professor John Lunec
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group2020
Professor Nicola Curtin
ATR inhibition potentiates parp inhibitor cytotoxicity in high risk neuroblastoma cell lines by multiple mechanisms2020
Elizabeth Gavens
Hany Gabra
Dr Al Gabriel
Dr David Jamieson
Detection of circulating and disseminated neuroblastoma cells using the Imagestream Imaging Flow Cytometer for use as predictive and pharmacodynamic biomarkers2020
Hannah Smith
Professor Nicola Curtin
DNA damage checkpoint kinases in cancer2020
Professor Nicola Curtin
Targeting the DNA Damage Response for the Treatment of High Risk Neuroblastoma2020
Nermine Basta
Dr Richard McNally
A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma2019
Philip Berry
Dr Jennifer Bonner
Calum Kirk
Huw Thomas
Professor John Lunec
et al.
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma2019
Julie Errington
Dr Leigh McDonald
The use of pharmacokinetically guided carboplatin chemotherapy in a pre-term infant with neuroblastoma-associated spinal cord compression2019
Arman Esfandiari
Professor John Lunec
Characterisation of the p53 pathway in cell lines established from TH-MYCN transgenic mouse tumours2018